GeneDx

WGS NASDAQ
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $62,422 $57,418 $53,303 $48,706
Gross Profit 32,979 25,575 25,259 18,757
EBITDA -7,169 -16,965 -18,321 -39,504
EBIT -12,817 -23,659 -26,993 -49,836
Net Income -20,239 -25,773 -42,286 -46,719
Net Change In Cash 62,422 57,418 53,303 48,706
Cost of Revenue -57,384
Free Cash Flow -16,856 -32,234 -41,090 -56,262
Cash 83,673 99,681 87,387 156,655
Basic Shares 26,062 25,978 25,788 25,418

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $202,566 $234,694 $212,195 $179,322
Gross Profit 60,622 -26,750 -16,602 4,026
EBITDA -127,828 -395,600 -424,342 -227,132
EBIT -163,662 -667,652 -446,149 -241,994
Net Income -175,767 -548,980 -245,390 -246,436
Net Change In Cash 202,566 234,694 212,195 179,322
Cost of Revenue -263,166
Free Cash Flow -185,858 -333,477 -211,220 -125,102
Cash 99,681 123,933 400,569 108,132
Basic Shares 24,311 10,236 3,275

Earnings Calls

Quarter EPS
2024-03-31 -$0.33
2023-12-31 -$0.69
2023-09-30 -$0.82
2023-06-30 -$1.64